Aspen Puts Up $1B For Pair Of GSK Blood Thinners
Aspen Pharmacare Holdings Ltd. furthered its expansion push on Monday with an agreement to pay £700 million ($1.1 billion) for a pair of GlaxoSmithKline PLC thrombosis drug brands and a related...To view the full article, register now.
Already a subscriber? Click here to view full article